Vaidya Rajesh Kotecha,
Secretary, Ministry of Ayush, Government of India
The Ayush sector today represents one of India’s fastest growing sectors, blending civilisational knowledge with modern innovation. The Ayush manufacturing industry has expanded nearly eightfold in the past 10 years, reaching an impressive market size of USD 43.4 billion, with a robust compounded annual growth rate (CAGR) of 17% between 2014 and 2020, reflecting both domestic confidence and rising global demand. Initiatives such as the Ayush Grid have strengthened digital integration and data-driven governance. The launch of the Ayush Quality Mark has reinforced quality assurance and global credibility. India’s growing footprint in Medical Value Travel (MVT) has further positioned Ayush as a trusted destination for holistic and integrative healthcare.
Over the past decade, Ayush manufacturing has expanded significantly, exports have increased steadily, and the global demand for Ayurveda and Yoga has grown across continents.
Building on this momentum, we have set an ambitious, yet achievable target of USD 200 billion by 2030. This requires accelerating growth from the current 17% CAGR to nearly 21%. While the target is undoubtedly challenging, it is well within reach through collective resolve, clear strategy, and coordinated action.
A Decade of Strong Foundations
Our confidence is rooted in the transformative reforms of the past decade. Since the creation of the Ministry of Ayush in 2014 under the visionary leadership of Hon’ble Prime Minister Shri Narendra Modi and guidance of Hon’ble Minister of State (IC) Sh. Prataprao Jadhav, the sector has witnessed structural strengthening.
Over the years, policy frameworks have been strengthened, regulatory mechanisms streamlined, research councils empowered, pharmacopeial standards enhanced, and public health integration expanded through the National Ayush Mission. Quality assurance mechanisms such as Good Manufacturing Practices (GMP) compliance have been strengthened, and advanced technologies including AI, machine learning, and digital platforms have begun transforming research, education, and service delivery.
The recent Union Budget announcements have further accelerated this transformation. The proposal to establish three new All India Institutes of Ayurveda will expand tertiary healthcare, postgraduate capacity, super-specialty services, and high-end translational research. The upgradation of Ayush pharmacies and drug testing laboratories will elevate certification ecosystems, promote World Health Organization (WHO)-GMP and standards of the National Accreditation Board for Testing and Calibration Laboratories (NABL), and build a larger pool of skilled professionals in quality control and regulatory compliance. The strengthening of the WHO Global Traditional Medicine Centre at Jamnagar will deepen international collaboration, regulatory harmonisation, and evidence-based global leadership.
Ayurveda must continue to play a central role in driving this growth. The expansion of apex institutions, integrative medicine initiatives, and research-driven validation has positioned Ayurveda as an evidence-informed, research-oriented, and globally respected healthcare discipline.
Beyond Economics: A Larger Purpose
The USD 200 billion goal is not merely an economic benchmark; it represents a larger mission. It is about ensuring accessible, affordable, and quality healthcare rooted in prevention and holistic well-being. It is about generating credible scientific evidence, enhancing export competitiveness, strengthening skill development, and building public trust through transparency and global standards.
India’s collaboration with the WHO in advancing traditional medicine underscores the global relevance of our efforts. The world today looks towards India for leadership in safe, effective, and evidence-based traditional medicine.
The Road to 2030: Accelerate, Consolidate, Lead
The coming years demand sharper focus and measurable outcomes. Achieving 21% CAGR will require:
Stronger industry–academia–research collaboration
Global branding and strategic market positioning
Regulatory agility aligned with international standards
Greater private investment and innovation
Comprehensive digital transformation across the value chain
Expansion of MVT and integrative healthcare services
Policy support provides direction, but sustained acceleration requires unity of purpose across manufacturers, practitioners, researchers, educators, investors, and entrepreneurs.
A Collective Call to Action
This is a decisive moment for the Ayush sector. We must move from incremental growth to mission-mode expansion. Together, we must identify bottlenecks, scale innovation, strengthen quality, and expand our global footprint. The journey to USD 200 billion will not be achieved by aspiration alone, but by coordinated action, measurable milestones, and shared accountability.
The path is clear. The opportunity is historic.
Mission 200 has begun. Let us move forward – together. I look forward to your support, ideas, and suggestions as we move ahead collectively chasing the Mission 200.
